The authors demonstrated that the Enb-TRAIL bi-functional molecule simultaneously engages both EGFR and DR5 on the surface of tumor cells, leading to amplification of the apoptotic signal and proving to be more effective than a combination treatment with Enb and TRAIL. The gene discussed is TNFSF10; the disease is neoplasm.